A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
NCT00764946
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
209
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Immunodeficiency Virus
Interventions
DRUG:
Comparator: raltegravir
Sponsor
Merck Sharp & Dohme LLC